Humana Financial Statements (HUM)
|
|
|
|
Report date
|
|
|
20.02.2020 |
18.02.2021 |
17.02.2022 |
16.02.2023 |
15.02.2024 |
|
30.10.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
64 888 |
77 155 |
83 064 |
92 870 |
106 374 |
|
115 010 |
|
Operating Income, bln rub |
|
|
3 712 |
4 957 |
3 745 |
3 800 |
4 013 |
|
2 617 |
|
EBITDA, bln rub |
? |
|
4 170 |
5 446 |
4 340 |
4 678 |
4 930 |
|
3 766 |
|
Net profit, bln rub |
? |
|
2 707 |
3 367 |
2 933 |
2 806 |
2 489 |
|
1 359 |
|
|
OCF, bln rub |
? |
|
5 284 |
5 639 |
2 262 |
4 587 |
3 981 |
|
-3 640 |
|
CAPEX, bln rub |
? |
|
736.0 |
964.0 |
1 316 |
1 120 |
1 004 |
|
704.0 |
|
FCF, bln rub |
? |
|
4 548 |
4 675 |
946.0 |
3 467 |
2 977 |
|
-4 344 |
|
Dividend payout, bln rub
|
|
|
291.0 |
323.0 |
354.0 |
392.0 |
431.0 |
|
434.0 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
10.7% |
9.59% |
12.1% |
14.0% |
17.3% |
|
31.9% |
|
|
OPEX, bln rub |
|
|
61 176 |
72 198 |
79 319 |
89 070 |
102 361 |
|
87 422 |
|
Cost of production, bln rub |
|
|
7 381 |
10 052 |
10 121 |
12 671 |
13 188 |
|
13 356 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
242.0 |
283.0 |
326.0 |
401.0 |
493.0 |
|
642.0 |
|
|
Assets, bln rub |
|
|
29 074 |
34 969 |
44 358 |
43 055 |
47 065 |
|
50 007 |
|
Net Assets, bln rub |
? |
|
12 037 |
13 728 |
16 080 |
15 311 |
16 262 |
|
17 565 |
|
Debt, bln rub |
|
|
5 891 |
6 980 |
12 820 |
11 424 |
11 656 |
|
13 022 |
|
Cash, bln rub |
|
|
4 054 |
4 673 |
3 394 |
5 061 |
21 320 |
|
24 149 |
|
Net debt, bln rub |
|
|
1 837 |
2 307 |
9 426 |
6 363 |
-9 664 |
|
-11 127 |
|
|
Ordinary share price, rub |
|
|
366.5 |
410.3 |
463.9 |
512.2 |
457.8 |
|
481.1 |
|
Number of ordinary shares, mln |
|
|
134.1 |
132.2 |
128.7 |
126.4 |
123.9 |
|
120.4 |
|
|
Market cap, bln rub |
|
|
49 134 |
54 237 |
59 693 |
64 751 |
56 707 |
|
57 926 |
|
EV, bln rub |
? |
|
50 971 |
56 544 |
69 119 |
71 114 |
47 043 |
|
46 799 |
|
Book value, bln rub |
|
|
7 932 |
8 952 |
2 349 |
4 404 |
5 019 |
|
7 975 |
|
|
EPS, rub |
? |
|
20.2 |
25.5 |
22.8 |
22.2 |
20.1 |
|
11.3 |
|
FCF/share, rub |
|
|
33.9 |
35.4 |
7.35 |
27.4 |
24.0 |
|
-36.1 |
|
BV/share, rub |
|
|
59.2 |
67.7 |
18.3 |
34.8 |
40.5 |
|
66.2 |
|
|
EBITDA margin, % |
? |
|
6.43% |
7.06% |
5.22% |
5.04% |
4.63% |
|
3.27% |
|
Net margin, % |
? |
|
4.17% |
4.36% |
3.53% |
3.02% |
2.34% |
|
1.18% |
|
FCF yield, % |
? |
|
9.26% |
8.62% |
1.58% |
5.35% |
5.25% |
|
-7.50% |
|
ROE, % |
? |
|
22.5% |
24.5% |
18.2% |
18.3% |
15.3% |
|
7.74% |
|
ROA, % |
? |
|
9.31% |
9.63% |
6.61% |
6.52% |
5.29% |
|
2.72% |
|
|
P/E |
? |
|
18.2 |
16.1 |
20.4 |
23.1 |
22.8 |
|
42.6 |
|
P/FCF |
|
|
10.8 |
11.6 |
63.1 |
18.7 |
19.0 |
|
-13.3 |
|
P/S |
? |
|
0.76 |
0.70 |
0.72 |
0.70 |
0.53 |
|
0.50 |
|
P/BV |
? |
|
6.19 |
6.06 |
25.4 |
14.7 |
11.3 |
|
7.26 |
|
EV/EBITDA |
? |
|
12.2 |
10.4 |
15.9 |
15.2 |
9.54 |
|
12.4 |
|
Debt/EBITDA |
|
|
0.44 |
0.42 |
2.17 |
1.36 |
-1.96 |
|
-2.95 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
1.13% |
1.25% |
1.58% |
1.21% |
0.94% |
|
0.61% |
|
| Humana shareholders |
